EX-8 2 drr0040ex8.htm


Exhibit 8


Dr. Reddy’s Laboratories Limited


Dr. Reddy’s Laboratories Limited is the parent company. Tabulated below is the list of subsidiaries, associates and joint ventures as of March 31, 2018:


Name of the subsidiary/joint venture  Country of
  Percentage of
Ownership Interest
Aurigene Discovery Technologies (Malaysia) Sdn. Bhd.  Malaysia   100%(3)
Aurigene Discovery Technologies Inc.  U.S.A.   100%(3)
Aurigene Discovery Technologies Limited  India   100%
beta Institut gemeinnützige GmbH  Germany   100%(8)
betapharm Arzneimittel GmbH  Germany   100%(8)
Cheminor Investments Limited  India   100%
Cheminor Employees Welfare Trust  India   Refer to footnote 16 
Chirotech Technology Limited  United Kingdom   100%(5)
Dr. Reddy’s Research Foundation  India   Refer to footnote 16 
Dr. Reddy’s Farmaceutica Do Brasil Ltda.  Brazil   100%
Dr. Reddy’s Laboratories (EU) Limited  United Kingdom   100%(10)
Dr. Reddy’s Laboratories (Proprietary) Limited  South Africa   100%(10)
Dr. Reddy’s Laboratories (UK) Limited  United Kingdom   100%(5)
Dr. Reddy’s Laboratories Canada, Inc.  Canada   100%(10)
Dr. Reddy's Laboratories Chile SPA. (from June 16, 2017)  Chile   100%(10)
Dr. Reddy’s Laboratories Inc.  U.S.A.   100%(10)
Dr. Reddy’s Laboratories International SA  Switzerland   100%(10)
Dr. Reddy’s Laboratories Japan KK  Japan   100%(10)
Dr. Reddy’s Laboratories Kazakhstan LLP  Kazakhstan   100%(10)
Dr. Reddy’s Laboratories Louisiana LLC  U.S.A.   100%(6)
Dr. Reddy’s Laboratories Malaysia Sdn. Bhd. (from July 10, 2017)  Malaysia   100%(10)
Dr. Reddy’s Laboratories New York, Inc.  U.S.A.   100%(10)
Dr. Reddy’s Laboratories Romania S.R.L.  Romania   100%(10)
Dr. Reddy’s Laboratories SA  Switzerland   100%
Dr. Reddy's Laboratories Taiwan Limited (from February 23, 2018)  Taiwan   100%(10)
Dr. Reddy’s Laboratories Tennessee, LLC  U.S.A.   100%(6)
Dr. Reddy’s Laboratories, LLC  Ukraine   100%(10)
Dr. Reddy’s New Zealand Limited.  New Zealand   100%(10)
Dr. Reddy’s Pharma SEZ Limited  India   100%
Dr. Reddy’s Singapore PTE Limited  Singapore   100%(10)
Dr. Reddy’s Srl  Italy   100%(11)
Dr. Reddy's Bio-Sciences Limited  India   100%
Dr. Reddy's Laboratories (Australia) Pty. Limited  Australia   100%(10)
Dr. Reddy's Laboratories SAS  Colombia   100%(10)
Dr. Reddy's Research and Development B.V. (formerly Octoplus B.V.)  Netherlands   100%(12)
Dr. Reddy's Venezuela, C.A.  Venezuela   100%(10)
Dr. Reddy’s (WUXI) Pharmaceutical Company Limited (from June 2, 2017)  China   100%(10)
DRANU LLC  U.S.A.   50%(13)
DRES Energy Private Limited  India   26%(14)
DRL Impex Limited  India   100%(15)
DRSS Solar Power Private Limited (liquidated on November 1, 2017)  India   26%(14) (2)
Eurobridge Consulting B.V.  Netherlands   100%(1)
Idea2Enterprises (India) Pvt. Limited  India   100%
Imperial Credit Private Limited  India   100%
Industrias Quimicas Falcon de Mexico, S.A. de CV  Mexico   100%
Kunshan Rotam Reddy Pharmaceutical Co. Limited  China   51.33%(4)
Lacock Holdings Limited  Cyprus   100%(10)





Name of the subsidiary  Country of
  Percentage of
Ownership Interest
OOO Dr. Reddy's Laboratories Limited  Russia   100%(10)
OOO DRS LLC  Russia   100%(9)
Promius Pharma LLC  U.S.A.   100%(6)
Reddy Antilles N.V.  Netherlands   100%
Reddy Holding GmbH  Germany   100%(10)
Reddy Netherlands B.V.  Netherlands   100%(10)
Reddy Pharma Iberia SA  Spain   100%(10)
Reddy Pharma Italia S.R.L.  Italy   100%(7)
Reddy Pharma SAS  France   100%(10)


(1) Indirectly owned through Dr. Reddy’s Research and Development B.V. (from March 29, 2018), formerly a subsidiary of Reddy Antilles N.V.


(2) Entities liquidated during the year.


(3) Indirectly owned through Aurigene Discovery Technologies Limited.


(4) Kunshan Rotam Reddy Pharmaceutical Co. Limited is a subsidiary, as the Company holds a 51.33% stake. However, the Company accounts for this investment by the equity method and does not consolidate it in the Company’s financial statements.


(5) Indirectly owned through Dr. Reddy’s Laboratories (EU) Limited.


(6) Indirectly owned through Dr. Reddy’s Laboratories Inc.


(7) Indirectly owned through Lacock Holdings Limited.


(8) Indirectly owned through Reddy Holding GmbH.


(9) Indirectly owned through Eurobridge Consulting B.V.


(10) Indirectly owned through Dr. Reddy’s Laboratories SA.


(11) Indirectly owned through Reddy Pharma Italia S.R.L.


(12) Indirectly owned through Reddy Netherlands B.V.


(13) DRANU LLC is consolidated in accordance with guidance available in IFRS 10.


(14) Accounted in accordance with IFRS 11 ‘Joint Arrangements’.


(15) Indirectly owned through Idea2Enterprises (India) Pvt. Limited.


(16) The Company does not have any equity interests in this entity, but has significant influence or control over it.